Teva Pharmaceutical Industries Ltd logo

Teva Pharmaceutical Industries Ltd - ADR

XBUL:TEV (Israel)   ADR
лв 15.85 (0%) Dec 23
At Loss
P/B:
4.12
Market Cap:
лв 17.96B ($ 9.55B)
Enterprise V:
лв 48.53B ($ 25.80B)
Volume:
4.00
Avg Vol (2M):
28.00
Trade In:

Business Description

Description
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Name Current Vs Industry Vs History
Cash-To-Debt 0.17
Equity-to-Asset 0.15
Debt-to-Equity 3.18
Debt-to-EBITDA 12.77
Interest Coverage 3.79
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.32
Distress
Grey
Safe
Beneish M-Score -2.46
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 0.95
9-Day RSI 7.42
14-Day RSI 16.39

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.89
Quick Ratio 0.61
Cash Ratio 0.24
Days Inventory 172.73
Days Sales Outstanding 76.07
Days Payable 104.63

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.7
Shareholder Yield % 5.62

Financials (Next Earnings Date:2025-01-29)

XBUL:TEV's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Teva Pharmaceutical Industries Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil лв) 31,544.407
EPS (TTM) (лв) -1.6
Beta 0
Volatility % 0
14-Day RSI 16.39
14-Day ATR (лв) 0.076749
20-Day SMA (лв) 16.4125
12-1 Month Momentum % 0
52-Week Range (лв) 15.85 - 18.1
Shares Outstanding (Mil) 1,133.05

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Teva Pharmaceutical Industries Ltd Filings

Filing Date Document Date Form
No Filing Data

Teva Pharmaceutical Industries Ltd Stock Events

Financials Calendars
Event Date Price(лв)
No Event Data

Teva Pharmaceutical Industries Ltd Frequently Asked Questions

What is Teva Pharmaceutical Industries Ltd(XBUL:TEV)'s stock price today?
The current price of XBUL:TEV is лв15.85. The 52 week high of XBUL:TEV is лв18.10 and 52 week low is лв15.85.
When is next earnings date of Teva Pharmaceutical Industries Ltd(XBUL:TEV)?
The next earnings date of Teva Pharmaceutical Industries Ltd(XBUL:TEV) is 2025-01-29.
Does Teva Pharmaceutical Industries Ltd(XBUL:TEV) pay dividends? If so, how much?
Teva Pharmaceutical Industries Ltd(XBUL:TEV) does not pay dividend.

Press Release

Subject Date
No Press Release